Announcement on Convening the 2025 Annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Earlier from Jianmin Pharmaceutical
- Announcement on Resolutions of the 6th Meeting of the 11th Board of Directors
- Announcement on the Approval of Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution for Marketing
- Announcement on Implementation of Providing Guarantee for Subsidiary's Bank Credit Line
- Announcement on Obtaining Notice of Approval for Drug Clinical Trial
- Report for Q3 2025
Later from Jianmin Pharmaceutical
- Announcement on Resolutions of the 7th Meeting of the 11th Board of Directors
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Resolutions of the 8th Meeting of the 11th Board of Directors
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical